Mr. Paley et al., LOW-DENSITY BARIUM AND BENTONITE MIXTURE VERSUS HIGH-DENSITY BARIUM -A COMPARATIVE-STUDY TO OPTIMIZE NEGATIVE GASTROINTESTINAL CONTRAST AGENTS FOR MRI, Magnetic resonance imaging, 15(9), 1997, pp. 1033-1036
The purpose of this study was to compare the patient tolerance and eff
icacy, as magnetic resonance imaging negative oral contrast agents, of
a mixture of clay compound bentonite and low density barium sulfate s
uspension with that of higher density barium sulfate, Twenty patients
were randomized into two groups: 10 patients receiving a mixture of lo
w concentration 60% w/v barium sulfate plus 2.5% w/v bentonite, and 10
patients receiving 220% w/v barium sulfate Liuqid-HD (E-Z-EM, Westbur
y, NY). Post-contrast Spin-echo (SE) T1- and T2-weighted images (WI) w
ere obtained on a 1.0T magnet, Two independent readers scored the over
all intraluminal signal intensity and delineation of the gastrointesti
nal tract and adjacent organs, Patient acceptance was evaluated via a
short questionnaire, by recording spontaneous comments and documenting
the quantity of contrast agent ingested, There was greater intralumin
al bowel signal reduction and organ delineation with 220% w/v barium t
han with the barium-bentonite mixture on both SE T1WI (p = 0.03) and S
E T2WI (p = 0.42), With both agents there was greater signal reduction
on SE T2WI than SE T1WI, Higher scores for organ delineation for both
contrast agents were seen with SE T1WI. With 220% w/v barium, there w
as significantly better delineation of the pancreatic body (p = 0.02)
and pancreatic tail (p = 0.02) on T1WI compared with SE T2WI, With the
barium-bentonite mixture, SE T1WI showed improved delineation of jeju
num compared with SE T2WI (p = 0.03), There were no statistically sign
ificant differences between the volume of contrast ingested in the two
groups, Abdominal cramps were recorded for one patient in each group,
These results suggest that barium-bentonite mixture, although useful
as a negative gastro-intestinal contrast agent, is not as effective as
220% w/v barium. Further studies with a larger patient population and
concentration optimization studies are needed. (C) 1997 Elsevier Scie
nce Inc.